Represented special purpose acquisition company Health Sciences Acquisitions Corporation 2 (HSAC2) in its business combination with Orchestra BioMed, a biomedical company.
-
Co-Chair, Capital Markets & Corporate; Co-Chair, SPACs -
Partner -
Co-Chair, Loeb & Loeb LLP